Compare SGHT & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGHT | GILT |
|---|---|---|
| Founded | 2011 | 1987 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 235.0M | 1.3B |
| IPO Year | 2021 | 1997 |
| Metric | SGHT | GILT |
|---|---|---|
| Price | $4.91 | $15.74 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $9.08 | ★ $19.00 |
| AVG Volume (30 Days) | 323.6K | ★ 653.1K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $77,363,000.00 | N/A |
| Revenue This Year | $11.67 | $15.06 |
| Revenue Next Year | $10.39 | $11.72 |
| P/E Ratio | ★ N/A | $42.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.11 | $5.43 |
| 52 Week High | $9.24 | $20.99 |
| Indicator | SGHT | GILT |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 39.88 |
| Support Level | $4.86 | $13.38 |
| Resistance Level | $5.25 | $18.84 |
| Average True Range (ATR) | 0.35 | 0.99 |
| MACD | 0.09 | -0.11 |
| Stochastic Oscillator | 57.26 | 12.65 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company operates in three operating segments: Gilat Commercial Division, Gilat Defense Division, and Gilat Peru Division. The majority of its revenue is generated from the Gilat Commercial segment.